TITLE

Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease

AUTHOR(S)
Auerbach, M.; Al Talib, K.
PUB. DATE
March 2008
SOURCE
Kidney International;Mar2008, Vol. 73 Issue 5, p528
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Serious adverse events that occur with the administration of iron dextran are due to the high molecular weight preparations. Conclusions that iron sucrose and ferric gluconate are safer than iron dextran may be premature. Published literature comparing safety profiles of available parenteral iron products is reviewed. Administration of iron salts to pre-dialysis patients with chronic kidney disease may not be optimal. We recommend the total dose infusion of low molecular weight iron dextran as an option for iron replacement.Kidney International (2008) 73, 528–530. doi:10.1038/sj.ki.5002779
ACCESSION #
29958141

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics